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Summary
The immune response is a highly specific reaction carried out by means of specialized cells that be-
long to the immune system. There are two types of immune response mechanisms aimed towards 
pathogens: non-specific, innate reactions, and specific, acquired reactions.
Acquired immunity, characterized by its specificity, is comprised of lymphocytes, including both T 
cell and B cell populations. The role of B lymphocytes is not limited to the humoral response, tho-
ugh the cellular immune response is carried out mainly by various T lymphocyte subpopulations. 
The reactions of the humoral and cellular responses complement and stimulate one another mutu-
ally – cytokines are their common linking element. The attachment of cytokines to their specific re-
ceptors activates a sequence of signals – either intracellular or between the cells of various systems. 
This organization of respective connections and reactions, including the functional relations be-
tween cells of the immune response, in its complexity, is best described as a cytokine network. 
The response of the immune system to surgical trauma can be looked at from both a local and a 
general perspective. Not only surgical trauma caused by tissue damage, however, influences the 
functioning of the immune system, but also the drugs and techniques used during anesthesia.
Our article is a presentation of the effects of medications used in anesthesia with respect to their 
influence on the cytokine network.
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The role of cyTokines in The immune sysTem
To survive, an organism must protect itself by means 
of fighting or adapting to invading microorganisms. In 
short, a stranger must either be accepted or destroyed.
The highly specific immune response is carried out by 
specialized tissues and cells comprising the immune sys-
tem which functions to protect organisms against foreign 
antigens.
There are 2 types of immunological responses to infec-
tious agents: non-specific, innate reactions, and specific, 
acquired defenses.
The immune system plays a key role in the inflammatory 
response and is anatomically and physiologically designed 
to protect the organism against harmful pathogens. Mono-
cytes/macrophages, B, T, NK and dendritic cells (DC) as 
well as granulocytes constitute the basic elements of the 
cellular immune response to infectious agents.
An important characteristic of acquired immunity is its 
specificity. The components of acquired immunity are 
antigen-presenting cells (APC) represented by DC and 
lymphocytes, including the T cell and B cell populations. 
Antibodies (immunoglobulins) are produced by activated, 
differentiated B lymphocytes. Antibodies, present in the 
blood, lymph and tissue fluids, have the ability to bind 
and neutralize antigens. The role of B lymphocytes is not, 
however, limited to the humoral response – functions 
such as cytokine synthesis, presenting antigens to T lym-
phocytes and helping to generate secondary lymphoid 
tissue are also important for the efficacy and functioning 
of the immune system [40].
The cellular immune response is carried out by various 
T lymphocyte subpopulations (helper T cells, cytotoxic 
T lymphocytes, and regulatory T cells), capable of rec-
ognizing specific antigens. The reactions of the humoral 
and cellular responses complement and stimulate one 
another mutually.
The 2 types of immune responses are linked by cytokines, 
which, in a sense, can be compared to reporters or jour-
nalists in that they play an important role in the distri-
bution of information.
Cytokines are released by cells of the immune system. They 
are characterized by pleiotropy, act in an auto-, para-, and 
endocrine manner, and either demonstrate synergistic ac-
tivity or act antagonistically towards one another.
Cytokines function via cell surface receptors. The bind-
ing of cytokines to their receptors usually activates a se-
quence of intracellular signals leading to a cell response. 
Cytokines are therefore vital in the inflammation process, 
playing an important role in both strengthening and sup-
pressing the inflammatory response.
This system of respective connections and reactions, in-
cluding the functional relations between cells of the im-
mune response, in its complexity, is best described as a 
cytokine network. 
The response of the immune system to surgical trauma 
can be estimated at both local and systemic levels. How-
ever, not only surgical trauma, caused by tissue dam-
age, may modify the function of the immune system, but 
also the drugs and techniques used during anesthesia. It 
seems, though, that at the core of immune system chang-
es is the modulation of the cytokine network. 
The main cytokines implicated in this response are IL-
6, TNF-α, IL-1 and IL-8. In reaction to stress caused by 
surgical trauma, macrophages release TNF-α and IL-1, 
which subsequently trigger the synthesis and release of 
other proinflammatory cytokines, such as IL-6, IL-8 [50] 
and numerous endogenous inflammatory mediators – 
growth factors, elements of the complement system, ad-
hesion molecules, thrombin and PAF, among others. 
The intensity of the cytokine response is directly relat-
ed to the size and scope of the surgical wound, which 
depends mainly on choice of operative technique [45]. 
Several results have confirmed the relationship between 
operative technique and cytokine response. They under-
line the importance of cytokine network changes that can 
play a role in the quality of post-operative care [8,19,68]. 
With respect to anesthesia, it is thought that cytokine 
equilibrium, broken down by surgical stress, is mostly 
influenced by medication, followed by the choice of an-
esthetic types and techniques.
The effect of drugs depends primarily on their plasma 
concentrations and duration as well as on function of 
the immune system.
It should be noted that findings suggesting the influence 
of anesthesia on the immune system were first presented 
by Graham as well as Gaylord and Simpson in 1911 and 
1916, respectively [31,35]. 
It is believed that in comparison to general anesthesia, 
regional anesthesia suppresses the immune system to 
a smaller extent. This was not confirmed, however, by 
studies performed by Dermitzaki et al., who did not find 
a difference in IL-6 and TNF-α serum concentrations be-
tween groups of patients that received either general or 
epidural anesthesia prior to cesarean section procedures. 
In both groups, an increase in IL-6 with no changes in the 
concentrations of TNF-α was observed [14]. The same re-
sults were obtained by other authors who examined the 
effect of regional and general anesthesia on plasma con-
centrations of IL-1, IL-6 and TNF-α in patients undergoing 
orthopedic surgery. In both groups the authors observed 
an increase of IL-6 and TNF-a with low values of IL-1. The 
results did not confirm significant differences in plasma 
concentrations of TNF-alpha and IL-6 between patients 
who underwent general or regional anaesthesia [24]. 763
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Gilliland et al. confirmed the positive correlation between 
IL-6 concentrations and the extent of surgical trauma and 
also the influence of these concentrations on the healing 
process and on post-operative immunosuppression [22]. 
Studies carried out on animals by Shimada et al. did not 
show anesthesia to exert any effect on either TNF or IL-6 
concentrations [60]. 
cyTokines in The face of some drugs used during anesThesia
Intravenous anesthetics
Of all the intravenous anesthetic agents, the following are 
noteworthy: thiopental, a representative of the first ever 
synthetic barbiturates; ketamine, a drug whose ‘golden 
age’ is gone but is still, nevertheless, put to use; and pro-
pofol, a popular drug that is administered often. Intra-
venous anesthetics have anti-inflammatory properties 
which, in most septic cases, can be considered to be ben-
eficial to the patient. 
Thiopental like many anesthetics acts on GABAA re-
ceptors whose presence on immune cells has been 
confirmed [1,27]. Ketamine acts via antagonism of N-
methyl-D-aspartate (NMDA) receptors. The anti-inflam-
matory effects of ketamine are still unclear but they 
could be connected with the suppression of macrophage 
production of TNF in the presence of bacteria [11]. Ac-
cording to results reported by Song et al., ketamine 
inhibits production of proinflammatory cytokines by 
reduction of hepatic nuclear factor kappa B (NF-ĸB) acti-
vation in experimental model of sepsis [63]. The nuclear 
factor kappa-B (NF-κB) proteins belong to a family of 
transcription factors that play a key role in the acti-
vation of many genes that regulate a large number of 
process such as synthesis of proinflammatory cytokines, 
cell proliferation and apoptosis, for example. NF-κB is 
also involved in the transcription of genes linked with 
sepsis. Thiopental and ketamine can inhibit the release 
of IL-1, IL-6, TNF-α and IL-8 triggered by endotoxin or 
lipopolysaccharide. Additionally, these drugs also in-
crease the level of IL-10, an anti-inflammatory cytokine 
[29,30,65,71]. 
This situation can be beneficial for septic patients be-
cause proinflammatory cytokines’ responses are well-
-known factors in the pathophysiology of organ dysfunc-
tion following endotoxemia. The overproduction of the 
proinflammatory cytokines causes the enhanced systemic 
inflammatory response syndrome (SIRS). However, the 
predominance of antiinflammatory cytokines may lead to 
higher risk of infections. Similarly, the effect of ketamine 
and thiopental on the function of mast cells appears to 
be disadvantageous for patients with a high risk of infec-
tion. The study of Fujimoto et al. showed that both these 
anesthetics have also suppressed mast cell chemotaxis 
and exocytosis [20]. Mast cells have a protective role in 
host defense against pathogens due to their involvement 
in innate and acquired immune responses to infection. 
So, the inhibitory effects of thiopental and ketamine on 
mast cell function may induce a higher risk of infection. 
Additionally, the ability of thiopental to inhibit monocy-
te chemotaxis and phagocytosis may also suppress the 
host response against pathogens and thereby enhance 
the risk of infection in immunocompromised patients 
[48,72]. Chemotaxis plays a crucial role in the inflamma-
tory response, because it is involved in the migration of 
leukocytes through the walls of blood vessels to sites of 
infection. 
We suppose that management of well-balanced sedation 
technique in patients with an impaired immune response 
could significantly reduce the risk of infection. 
The increased risk of infection in patients with continu-
ous barbiturate therapy may provide new approaches to 
modulate the immune response. 
Zeyneloglu et al. in their study with children undergo-
ing cardiac surgery found no significant differences be-
tween ketamine and isoflurane on the magnitude of the 
systemic inflammatory response. Both anesthetics had 
similar effects on the concentrations of IL-6 in plasma 
and bronchoalveolar lavage fluid [74]. But it has also 
been demonstrated that a low dose of ketamine used as 
preemptive anesthesia caused a perioperative decre-
ase of IL-6 concentration independently of the kind of 
surgery [54,55]. 
Moreover, the application of low-dose ketamine also sup-
pressed the in vitro mitogen response and release of IL-1β, 
IL-2, IL-6, and TNF-α, by peripheral blood mononuclear 
cells (PBMC) in patients undergoing abdominal surgery [3]. 
So using ketamine may be an effective preventative 
method of impeding inflammation in response to surgi-
cal stress. Because the overproduction of these cytokines 
is connected with the severity of the inflammatory re-
sponse and postoperative complications this manage-
ment seems to be effective in reduction of postoperative 
complications as well. In addition, the results of many 
studies have shown that ketamine could be helpful in 
reducing the amount of requested analgesics and post-
operative pain score [44,47,48]. 
The preemptive epidural administration of ketamine did 
not change the concentrations of IL-6, TNF or IL-10 cyto-
kines in the plasma of examined patients but diminished 
the pain intensity after surgery [61]. To the contrary, pre-
emptive ketamine given intravenously not only reduced 
the plasma concentration of IL-6 and TNF-α but also was 
associated with lower pain intensity and postoperative 
consumption of analgesics when compared with a con-
trol group [15]. 
It is suggested with high probability that ketamine did not 
affect cytokine levels due to low blood concentration af-
ter epidural administration. Epidural ketamine improved 
pain relief by the inhibitory action of NMDA receptors 
in spinal cord without any changes in cytokine concen-764
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trations. In conclusion, the choice of way of ketamine 
administration should be associated with the patient’s 
condition and his capacity for defense against infection. 
Propofol (2,6-diisopropylphenol) is routinely used for 
short-term sedation, maintenance of anesthesia and for 
long-term sedation in critical patients. Propofol is char-
acterized by perfect anesthetic effects and anti-inflam-
matory, antioxidant properties [42]. 
The molecular mechanisms for anti-inflammatory and 
antioxidant activity of propofol have been a subject of 
interest for many studies; however, they are still unclear.
The drug owes these properties to its chemical resem-
blance to endogenous tocopherols. Studies have shown 
that after the use of propofol patients exhibit a substan-
tial increase in γ tocopherol, an agent causing inhibition 
of the inflammatory response. 
The anti-inflammatory properties of propofol are also 
demonstrated by its ability to weaken the synthesis of 
prostaglandins (PGE) by LPS activated monocytes [9]. 
In addition, propofol blocks the expression of ICAM-1 and 
VCAM-1 cellular adhesion molecules, which are crucial in 
the migration of leukocytes through the endothelium [13]. 
The studies conducted by González-Correa et al. have 
shown that propofol reduced the concentration of cyto-
kines (IL-1, TNF-α, IL-6) and stimulated the neutrophils 
to nitric oxide (NO) synthesis [23,62]. 
The anti-inflammatory effect of propofol has been con-
firmed by its inhibition of LPS stimulated macrophages, 
which can be regarded as a laboratory endotoxemic 
model [25]. 
The results presented by Chung-Hsi et al. indicated that 
propofol attenuated the inflammatory activity of LPS-in-
duced macrophages in an animal septic model by inhibi-
tion of the signal transduction including the reactive oxy-
gen species generation/Akt signaling/I kappabeta kinase/
NF-κB pathway (ROS/Akt/IKKβ/NF-κB). They confirmed 
the suppressive influence of propofol treatment on LPS-
induced cellular inflammatory responses respectively, 
in macrophages. Furthermore, the authors provided evi-
dence that the antioxidant properties of propofol have 
been associated with decrease of antioxidant activity ca-
pacity also via regulation of the ROS/Akt/NF-κB pathway. 
The antioxidant properties of propofol have also been 
confirmed by other investigators. Their results showed 
that propofol could reduce free radical level and the in-
tensity of oxidative stress [2,38]. 
Oxidative stress is characterized as an imbalance between 
generation of reactive oxygen species (ROS) and inade-
quate antioxidant defense systems including endogenous 
enzymes and exogenous antioxidants. The significant in-
crease of ROS following many stressful events can initiate 
the damage to cellular DNA, lipids and proteins that in 
surgical patients may lead to the impairment of wound 
healing and higher risk of infection. 
The anti-inflammatory effect of propofol was also ob-
served in vitro in LPS stimulated macrophages. Propofol 
has remarkable regulatory activity on NO generation via 
stimulation of constitutive nitric oxide synthase and in-
hibition of inducible nitric oxide synthase (iNOS) [25]. 
The inhibitory effects were dose and time manner depen-
dent; a higher dose of propofol attenuated synthesis more 
strongly when given immediately after LPS stimulation. 
NO synthase (iNOS) plays a role in induction of NO release 
from macrophages due to inflammatory reactions. The 
excess of NO may cause damage of tissue and organ failu-
re. This effect should not always be beneficial to patients 
in acute states compared to those with chronic inflam-
mation when suppression of the chronic inflammatory 
response may have more advantages. 
Furthermore, propofol causes an increase in anti-inflam-
matory IL-10 concentrations.
The higher concentration of anti-inflammatory cytokine 
in patients given propofol is additional proof of the drug’s 
anti-inflammatory properties. IL-10 blocks the synthesis 
of pro-inflammatory cytokines and stimulates the release 
of IL-1 receptor antagonist (IL-1Ra). 
The use of propofol anesthesia has also been shown to be 
more beneficial than isoflurane from the point of view 
of post-operative risk of infection. The results of studies 
examining the IL-6/IL-10 ratio (factor indicating attenu-
ation of the immune imbalance) demonstrated increase of 
this ratio after propofol and its decrease after isoflurane 
administration – findings which can subsequently lead 
to the reduction of post-operative risk of infection [69]. 
Like ketamine, propofol impairs the chemotaxis and 
oxidative ability of macrophages in a dose-dependent 
manner. The investigators explained that decline of mac-
rophage activity could be followed by lowering of mem-
brane potential of mitochondria and synthesis of cellu-
lar adenosine triphosphate [12], which in turn leads to 
attenuation of synthesis of TNF-alpha, IL-1 beta and IL-6 
proinflammatory cytokines. 
Sung et al. showed that propofol could limit an excess of 
inflammatory response followed by stress involving isch-
emia and reperfusion [64]. In their studies, they evaluated 
the effect of propofol in relation to the hepatic Kupffer 
cells that are known as a major source of proinflammatory 
cytokine release during the acute phase inflammatory 
response. The results showed reduction of intracellular 
Ca++ and TNF-α mRNA expression in the cells in presence 
of propofol. The protective function of propofol on cells 
after ischemia-reperfusion have also been confirmed by 
Feng et al. The authors demonstrated significantly lower 765
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expression of NF-kappa B and IL-1, TNF-alpha and ICAM-
1 in cells taken from animals which were given propofol 
during transient focal cerebral ischemia-reperfusion [16]. 
A study examining the influence of propofol (used in two 
doses, 3.5 or 10 μg/ml) and thiopental (one dose) on Th1/
Th2 equilibrium evaluated by levels of IFNγ, IL-4 and IL-2 
released by lymphocytes showed the different effects of 
these anesthetics on the immune response. In contrast to 
propofol, thiopental caused a decrease in IFNγ and IL-4 
concentrations without affecting IL-2 concentrations. 
In this study, only propofol infusions at a higher dose 
caused an increase of IFN-γ/IL-4 ratio, while propofol 
used at a lower dose did not change the concentrations 
of cytokines [56]. 
T helper cells (Th lymphocytes) are a subpopulation of 
lymphocytes that play a supportive role in the humoral 
and cellular response through direct contact and via cy-
tokine release. The Th1 and Th2 subtypes of helper cells 
are distinguished by differences in function, in types of 
cytokines released and in CD molecule expression. For 
instance, Th1 lymphocytes, releasing IL-2 and IFN-γ, 
strengthen the cellular immune response. Th2 lympho-
cytes produce IL-4, IL-5, IL-10 and IL-13 cytokines, stimu-
lating the synthesis of many antibodies by B lymphocytes, 
which in turn strengthens the humoral immune response. 
The growth and differentiation autocrine factor for Th1 
cells is IL-2 and for Th2 cells – IL-4.
In summary, the contribution of anesthetics in the func-
tioning of the cytokine network is seen in both humoral 
and cellular mediated immunity.
Opioids
Studies have shown the existence of mutual connections 
between opioids and the immune system. Both suppres-
sive and stimulatory effects of opioids on the immune 
system have been described. Opioids exert their effects 
either directly through receptors (µ, δ, κ) which are wi-
dely located on both neural and immune cells or via the 
autonomic and central nervous systems [17,28,39,46]. 
Opioids cause the modulation of both innate and adapti-
ve immunity, including cytokine and immunoglobulin 
synthesis, activation of natural killer cells (NK) and pha-
gocytosis [17,52]. 
Opioid receptors are commonly expressed by peripheral 
immune and glial cells and the suppressive activity of 
opioids on the immune system is demonstrated via both 
centrally and peripherally distributed receptors. 
As an example, long-term (12 months) epidurally given 
morphine alone or with bupivacaine caused a significant 
increase of µ receptors mRNA in lymphocytes, which like-
ly causes attenuation of cytokine synthesis. Additionally, 
at the same time a lowering of the percentage of NK was 
observed [7]. Opioids have the ability to modulate the 
immune responses including cell proliferation and regu-
lation of cytokine synthesis and secretion [52].
Roy et al. showed the influence of chronic morphine tre-
atment on Th1/Th2 balance. Morphine induces the pro-
duction of TGF-β by stimulated lymphocytes, monocytes 
and macrophages – this concerns mainly long-term the-
rapy which also causes a rise in IL-4 and IL-5 concentra-
tions and a decrease in IL-2 and IFN-γ [51]. Furthermore, 
Vassou et al. presented evidence that opioids could mo-
dulate humoral immunity by decreasing both antibody 
secretion by normal B-lymphocytes and proliferation of 
multiple myeloma cells [67]. 
Studies investigating the influence of opioids on the pro-
duction of pro-inflammatory monocyte/macrophage-de-
rived cytokines have demonstrated a significant dimi-
nishing of TNFα, IL-1 and IL-6 concentrations following 
morphine treatment [17]. In turn, studies carried out by 
Makimura et al. showed a correlation between the con-
centrations of certain cytokines (IL-8, IL-12, MIP-1α) and 
analgesic tolerance to morphine. Lower concentrations of 
the mentioned cytokines were found in patients requiring 
higher doses of morphine in long-term therapy. A lower 
level of examined cytokines was also found in patients 
with symptoms of higher resistance to morphine [41]. 
The central activity of opioids is focused mainly on glial 
cells, which demonstrated proinflammatory activation 
and which are the main source of cytokines. Morphi-
ne causes activation of glial cells that subsequently re-
lease proinflammatory cytokines including IL-1β, IL-6, 
and TNF-α acting in opposition to the analgesic effects 
of morphine. The stimulation of cytokine release is irre-
spective of the frequency and time period of morphine 
administration. Considering the short cytokine response 
time (about 5 min) to morphine, it can be assumed that 
morphine stimulates the release of stored reserves but 
not their synthesis. The results presented by Shavit et 
al. showed that IL-1 can decrease the analgesic potential 
of morphine and plays a role in developing tolerance to 
morphine [59].
On the other hand, Byrne et al. found that IL-1β can af-
fect the expression of the opioid receptors in glial cells. 
The authors confirmed the ability of IL-1β to up-regulate 
opioid receptors (µ, δ. Κ) in astrocytes [6].
The pathways of morphine-induced inhibition of pro-
inflammatory cytokine production via µ receptors are 
different but finally lead to the depression of NF-κB si-
gnaling. On one hand, the depression of NF-κB signaling 
is caused by activation of the cAMP response, and on the 
other, it follows the increase of nitric oxide activation 
after stimulation of the μ3 opiate receptor on monocy-
tes [32]. There is evidence that Toll-like receptors (TLR4, 
TLR2) are involved in the immunomodulatory effect of 
morphine. Stimulation of TLR signaling causes activation 
of intracellular pathways: the NF-κB and MAPK pathways 
play leading roles in the proinflammatory response, whi-766
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le the PI3K/Akt1 pathway is related more to processes of 
survival and apoptosis [53]. 
For example, in the development of morphine tolerance, 
hyperalgesia and respiratory depression are linked to the 
activity of Toll-like receptor 4 (TLR4) in glial cells. The 
proinflammatory glial response to opioids is stimulated 
though TLR4, whose activity can inhibit opioid analgesia. 
A study on animals showed the reduction of opioid toler-
ance and hyperalgesia as well stronger opioid analgesia 
following the blockade of TLR4 pathway signaling. Ac-
cording to these authors’ suggestions, systemic morphine 
analgesia might be in opposition to TLR4 signaling [26,52]. 
As first, Bonnet et al. revealed morphine inhibition of TNF 
and IL-6 production in TLR2-stimulated monocytes. Like 
TLR4, the stimulation of TLR2 also provokes the synthesis 
of TNF and IL-6 via NF-κB pathway signaling. In the same 
study the authors did not confirm their hypothesis that 
the elevation of IL-10 production would be involved in 
morphine immunomodulatory effects [4]. The presented 
results are important because TLR2 plays a pivotal role in 
identifying Gram-positive bacteria components associa-
ted with the development of severe infection.
The study of Franchi et al. demonstrated that morphine 
has been able to decrease TLR4 mRNA via the µ receptor. 
Taken together, morphine regulates the cell signaling pa-
thway in TLR2 or TLR4 stimulated macrophages through 
inhibition of the receptor and NF-κB pathway during the 
initial stage of pathogen recognition. This mechanism se-
ems to explain the peripheral suppressive effect of mor-
phine on innate immunity [18]. 
Thus, the anti-inflammatory activity of opioids appears 
to be mediated by different signaling ways. 
The results of the Levis et al. study showed that one of 
its main metabolites – morphine-3-glucuronide (M3G) 
– caused enhancement of pain following stimulation of 
the TLR4 receptor and release of IL-1 from the glia. Such 
a function has not been observed with morphine-6-glu-
curonide (M6G) [37]. 
In contrast to M3G, whose activity is associated with allo-
dynia and hyperalgesia, morphine-6-glucuronide has high 
affinity for the opioid receptor. Therefore, the attenuation 
of morphine-induced hyperalgesia though the inhibition 
of TLR4 signaling seems to be a noteworthy suggestion.
Studies performed in genetically modified animals con-
firmed the participation of µ receptor activation in TNF-α, 
IL-1 and IL-6 release by macrophages following morphine 
stimulation [10]. 
Remifentanil, in comparison with fentanyl, causes a de-
crease in the IFN-γ/IL-10 ratio (a drop in IFN-γ), which 
mirrors the equilibrium of Th1/Th2. Concentrations of 
IL-6, TNF, IL-10 and IL-2 were not shown to change upon 
treatment with remifentanil or fentanyl [5,70]. 
Benzodiazepines
Midazolam, a representative of benzodiazepines, is used 
mainly in premedication and sometimes intraoperatively 
during anesthesia. Midazolam exerts its action via central 
and peripheral benzodiazepine receptors (CBR/PBR). The 
expression of PBR found on the surface of macrophages 
allows benzodiazepine to modulate pro-inflammatory 
and anti-bacterial functions of macrophages by blocking 
their ability to produce superoxide anions as well as IL-1, 
TNF and IL-6 cytokines [66,73]. 
Both midazolam and propofol modulate the transport 
and release of IL-8. Activation of leukocytes via LPS in 
the presence of propofol and midazolam causes a decre-
ase in the concentration of extracellular IL-8 while the 
intra-cellular concentration remains unchanged [21]. The 
suppression of IL-8 release may increase the risk of infec-
tion in the post-operative period.
influence of conTrolled venTilaTion on cyTokines
Controlled ventilation, through trauma to alveolar cells 
and mechanical stress, can destabilize the ventilation/
perfusion ratio (hyperperfusion), causing release of 
inflammatory mediators, leading to worsening of gas 
exchange in the post-operative period [34]. 
Damage to the alveoli from pressure changes with the 
use of PEEP is also a traumatizing factor, as are the in-
halational anesthetics themselves [43]. The inhaled sub-
stances cause irritation of the endothelium, which can 
in turn lead to stimulation of endothelial cells and their 
subsequent release of proinflammatory cytokines and 
mediators. 
Damage to lung tissue is directly proportional to venti-
lation volume and translates into lung capillary trauma 
and the accumulation of neutrophils. Another factor that 
can cause lung tissue damage leading to increased release 
of cytokines is intra-operative hypoxemia.
Results presented by Schilling T et al. showed that both 
the type of ventilation and the medication used during 
general anesthesia had an effect on proinflammatory 
cytokine concentration levels [57,58]. Concentrations 
of TNF-α, IL-8 and IL-1 in bronchoalveolar lavage fluid 
were shown to be higher in patients given propofol than 
in those who received inhalational anesthetics – des-
flurane and sevoflurane. IL-6 concentrations increased 
irrespective of the type of anesthetic used. Contrary 
to this local response, the systemic (general) response 
was insignificant.
Similar results were obtained by other authors with re-
spect to isoflurane and propofol [33]. Namely, TNF-α and 
IL-8 concentrations in bronchoalveolar lavage fluid and 
plasma were higher after propofol administration in re-
lation to patients treated with isoflurane. Isoflurane de-
creased the inflammatory response associated with one 767
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lung ventilation during thoracic surgery and may be pre-
ferable to propofol in patients with expected high levels 
of proinflammatory cytokines. 
Consequently, it can be confirmed that inhalational ane-
sthetics have protective (anti-inflammatory) properties. 
This finding is important especially in patients with an 
altered cytokine network equilibrium, such as those with 
autoimmune disorders or cancer.
Sevoflurane, isoflurane and enflurane inhibit the release 
of IL-1-β and TNF-α from peripheral blood mononuclear 
cells (PBMC), which can reduce the immunological po-
tential of these cells in the presence of cancerous cells 
or foreign microorganisms. This role of inhalational ane-
sthetics may, however, be difficult to identify and there-
fore go unnoticed. 
conclusion and ouTlook for The fuTure
Post-operative, immunological complications such as 
poor wound healing or infection are rare in patients 
with properly functioning immune systems. However, 
in patients with immune disorders – either externally 
inflicted or with autoimmune problems – the interac-
tion of anesthetic drugs with their receptors found on 
cytokine-producing cells is substantially increased, le-
ading to modulations in the response to surgical stress. 
For this reason, choices of pain relief therapy should 
be carefully considered with respect to immune sup-
pression.
Doctors currently anesthetize growing numbers of AIDS 
patients as well as people with autoimmune diseases in 
whom long-term anesthetic administration coupled with 
heightened surgical stress can lead to the uncontrolled 
development of SIRS and multi-organ failure. Patients 
with cancer form a separate group of subjects in whom 
both the disease and applied therapy cause weakening 
of the immune response; if these patients are then addi-
tionally subjected to the suppressive effects of anesthe-
tics, the risk of post-operative complications and cancer 
proliferation increase extensively. Certain drugs, howe-
ver, such as propofol, may lead to decreases in cancerous 
growth rates via increased activity of cytotoxic T lympho-
cytes (CTL) and lowered TGF concentrations [36]. 
Linking anesthetics to the immune system has created 
new therapeutic advantages as well as challenges. It sho-
uld be anticipated that the growth of empirical knowledge 
concerning the mechanism of action of anesthetics will 
facilitate their more favorable administration taking into 
account the functioning of the cytokine network.
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